JIN Historical Balance Sheet

ZJYL Stock   0.71  0.02  2.90%   
Trend analysis of JIN MEDICAL INTERNATIONAL balance sheet accounts such as Total Assets of 29.8 M, Short Long Term Debt Total of 14 M, Other Current Liabilities of 592.7 K or Total Current Liabilities of 10.9 M provides information on JIN MEDICAL's total assets, liabilities, and equity, which is the actual value of JIN MEDICAL INTERNATIONAL to its prevalent stockholders. By breaking down trends over time using JIN MEDICAL balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining JIN MEDICAL INTERNATIONAL latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether JIN MEDICAL INTERNATIONAL is a good buy for the upcoming year.

JIN MEDICAL Inventory

4.88 Million

  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

About JIN Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of JIN MEDICAL INTERNATIONAL at a specified time, usually calculated after every quarter, six months, or one year. JIN MEDICAL Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of JIN MEDICAL and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which JIN currently owns. An asset can also be divided into two categories, current and non-current.

JIN MEDICAL Balance Sheet Chart

At this time, JIN MEDICAL's Cash And Short Term Investments are quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 188.9 M this year, although the value of Other Current Liabilities will most likely fall to about 592.7 K.

Total Assets

Total assets refers to the total amount of JIN MEDICAL assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in JIN MEDICAL INTERNATIONAL books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on JIN MEDICAL balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of JIN MEDICAL INTERNATIONAL are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from JIN MEDICAL's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into JIN MEDICAL INTERNATIONAL current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
At this time, JIN MEDICAL's Cash And Short Term Investments are quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 188.9 M this year, although the value of Other Current Liabilities will most likely fall to about 592.7 K.
 2024 2025 (projected)
Short and Long Term Debt Total13.3M14.0M
Total Assets52.7M29.8M

JIN MEDICAL balance sheet Correlations

0.7-0.560.890.980.82-0.74-0.520.530.93-0.890.940.030.010.780.87-0.120.870.88-0.640.840.820.891.00.70.82
0.7-0.90.350.810.95-0.94-0.210.030.89-0.740.87-0.530.550.90.84-0.730.790.79-0.30.910.620.350.711.00.69
-0.56-0.9-0.21-0.67-0.870.90.280.12-0.810.59-0.740.57-0.71-0.92-0.690.78-0.63-0.650.01-0.81-0.4-0.21-0.57-0.9-0.56
0.890.35-0.210.770.49-0.37-0.450.640.66-0.680.680.43-0.290.450.630.330.670.74-0.640.570.71.00.870.350.78
0.980.81-0.670.770.91-0.85-0.510.440.98-0.920.99-0.150.140.880.91-0.320.90.88-0.590.90.810.770.980.810.78
0.820.95-0.870.490.91-0.94-0.330.070.96-0.810.95-0.40.50.960.82-0.620.770.76-0.330.880.610.490.830.950.65
-0.74-0.940.9-0.37-0.85-0.940.49-0.19-0.920.85-0.90.61-0.41-0.93-0.890.74-0.85-0.810.41-0.94-0.7-0.37-0.75-0.94-0.67
-0.52-0.210.28-0.45-0.51-0.330.49-0.58-0.460.71-0.480.170.35-0.4-0.540.07-0.56-0.520.61-0.46-0.61-0.45-0.52-0.21-0.46
0.530.030.120.640.440.07-0.19-0.580.28-0.530.330.12-0.750.080.560.290.640.57-0.820.430.780.640.530.030.52
0.930.89-0.810.660.980.96-0.92-0.460.28-0.880.99-0.260.330.960.89-0.460.860.86-0.440.930.720.660.930.890.76
-0.89-0.740.59-0.68-0.92-0.810.850.71-0.53-0.88-0.920.270.06-0.76-0.920.32-0.91-0.890.77-0.86-0.9-0.69-0.9-0.74-0.79
0.940.87-0.740.680.990.95-0.9-0.480.330.99-0.92-0.250.250.920.9-0.430.870.85-0.530.910.770.680.950.870.74
0.03-0.530.570.43-0.15-0.40.610.170.12-0.260.27-0.25-0.38-0.41-0.390.92-0.35-0.220.06-0.44-0.240.430.0-0.53-0.03
0.010.55-0.71-0.290.140.5-0.410.35-0.750.330.060.25-0.380.540.05-0.67-0.040.00.620.23-0.31-0.280.020.55-0.03
0.780.9-0.920.450.880.96-0.93-0.40.080.96-0.760.92-0.410.540.79-0.640.750.72-0.210.880.550.450.80.90.6
0.870.84-0.690.630.910.82-0.89-0.540.560.89-0.920.9-0.390.050.79-0.451.00.97-0.70.980.930.630.870.840.86
-0.12-0.730.780.33-0.32-0.620.740.070.29-0.460.32-0.430.92-0.67-0.64-0.45-0.39-0.29-0.09-0.55-0.190.33-0.15-0.73-0.11
0.870.79-0.630.670.90.77-0.85-0.560.640.86-0.910.87-0.35-0.040.751.0-0.390.97-0.740.960.960.670.880.790.86
0.880.79-0.650.740.880.76-0.81-0.520.570.86-0.890.85-0.220.00.720.97-0.290.97-0.70.940.920.740.880.790.96
-0.64-0.30.01-0.64-0.59-0.330.410.61-0.82-0.440.77-0.530.060.62-0.21-0.7-0.09-0.74-0.7-0.54-0.9-0.64-0.64-0.3-0.64
0.840.91-0.810.570.90.88-0.94-0.460.430.93-0.860.91-0.440.230.880.98-0.550.960.94-0.540.840.570.850.910.83
0.820.62-0.40.70.810.61-0.7-0.610.780.72-0.90.77-0.24-0.310.550.93-0.190.960.92-0.90.840.70.820.620.83
0.890.35-0.211.00.770.49-0.37-0.450.640.66-0.690.680.43-0.280.450.630.330.670.74-0.640.570.70.870.350.78
1.00.71-0.570.870.980.83-0.75-0.520.530.93-0.90.950.00.020.80.87-0.150.880.88-0.640.850.820.870.710.82
0.71.0-0.90.350.810.95-0.94-0.210.030.89-0.740.87-0.530.550.90.84-0.730.790.79-0.30.910.620.350.710.69
0.820.69-0.560.780.780.65-0.67-0.460.520.76-0.790.74-0.03-0.030.60.86-0.110.860.96-0.640.830.830.780.820.69
Click cells to compare fundamentals

JIN MEDICAL Account Relationship Matchups

JIN MEDICAL balance sheet Accounts

202020212022202320242025 (projected)
Total Assets21.9M20.9M32.9M45.8M52.7M29.8M
Other Current Liab754.8K725.1K511.8K711.6K640.4K592.7K
Total Current Liabilities7.9M5.7M8.9M17.2M19.7M10.9M
Total Stockholder Equity14.0M15.2M24.0M28.8M33.1M19.0M
Property Plant And Equipment Net2.1M1.6M1.5M1.7M1.5M1.5M
Current Deferred Revenue975.7K1.7M830.3K797.1K717.4K849.0K
Net Debt983.7K(3.7M)(4.8M)3.5M3.1M3.3M
Retained Earnings11.9M14.4M16.9M20.0M23.0M14.7M
Accounts Payable5.4M4.1M3.4M3.0M2.7M3.5M
Cash3.7M4.8M6.9M8.1M9.4M5.0M
Non Current Assets Total2.5M2.0M1.8M3.0M2.7M1.9M
Non Currrent Assets Other366.4K857.3K864.6K152.5K175.3K166.6K
Cash And Short Term Investments2.8M5.7M7.1M26.8M30.8M32.3M
Net Receivables6.0M4.3M4.2M8.8M7.9M5.3M
Short Term Investments2.1M2.3M9.8M18.6M21.4M22.5M
Liabilities And Stockholders Equity20.8M21.9M20.9M45.8M52.7M28.6M
Inventory6.9M6.7M5.1M5.2M4.7M4.9M
Other Current Assets758.9K969.6K1.0M2.1M2.4M2.5M
Total Liab7.9M5.7M8.9M17.2M19.8M10.9M
Total Current Assets19.4M18.9M31.1M42.8M49.2M27.2M
Accumulated Other Comprehensive Income1.1M2.1M740.3K2.0M2.3M1.5M
Intangible Assets185.1K163.2K154.4K1.1M1.3M1.4M
Net Invested Capital14.0M15.2M28.1M40.1M46.2M24.4M
Property Plant And Equipment Gross5.8M5.3M5.2M5.8M6.7M6.1M
Net Working Capital11.5M13.2M22.2M25.7M29.5M17.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.676
Earnings Share
0.02
Revenue Per Share
0.15
Quarterly Revenue Growth
0.353
Return On Assets
0.0578
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.